Aug 18, 2026 04:05PM

Aug 4, 2026 04:05PM

Jul 16, 2026 04:05PM

Jul 1, 2026 04:05PM

Jun 16, 2026 04:00PM

Apr 16, 2026 04:05PM

Mar 2, 2026 06:01AM FDA accepts rusfertide application with priority review for blood disorder

Mar 2, 2026 02:00AM

Jan 5, 2026 07:03AM

Jan 5, 2026 07:00AM

Dec 8, 2025 02:54AM

Dec 6, 2025 09:30AM

Oct 13, 2025 05:04AM

Oct 10, 2025 11:27AM Protagonist Therapeutics stock surges after J&J acquisition talks report

Jun 1, 2025 08:00AM

Mar 3, 2025 06:46AM

Mar 3, 2025 06:45AM

Jan 6, 2025 04:05PM

Nov 22, 2024 05:21AM

Jan 31, 2024 04:09PM

Jan 31, 2024 04:05PM Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Oct 30, 2023 04:08PM

Oct 30, 2023 04:05PM

Nov 16, 2022 04:05PM

Apr 19, 2022 04:15PM

Oct 11, 2021 09:21AM

Sep 15, 2021 05:05PM

Mar 23, 2021 09:28AM Pre-Open Movers 03/23: (ORMP) (TKAT) (BLFS) Higher; (FREQ) (ANIX) (IONX) Lower (more...)

Mar 22, 2021 05:44PM

Dec 16, 2020 09:23AM

May 24, 2018 04:30PM

Mar 26, 2018 09:13AM

May 30, 2017 09:32AM

1,185,433 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All